Cargando…

Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance

BACKGROUND AND PURPOSE: A sub-mm resolution Complementary Metal Oxide Semiconductor sensor has been developed for stereotactic radiotherapy quality assurance. Herein we evaluate its basic dosimetric performance and its application for linac C-arm stereotactic body radiotherapy (SBRT) plan quality as...

Descripción completa

Detalles Bibliográficos
Autores principales: Stepanek, Chris J., Haynes, Jackie A., Fletcher, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900433/
https://www.ncbi.nlm.nih.gov/pubmed/36755894
http://dx.doi.org/10.1016/j.phro.2023.100418
_version_ 1784882846969626624
author Stepanek, Chris J.
Haynes, Jackie A.
Fletcher, Sally
author_facet Stepanek, Chris J.
Haynes, Jackie A.
Fletcher, Sally
author_sort Stepanek, Chris J.
collection PubMed
description BACKGROUND AND PURPOSE: A sub-mm resolution Complementary Metal Oxide Semiconductor sensor has been developed for stereotactic radiotherapy quality assurance. Herein we evaluate its basic dosimetric performance and its application for linac C-arm stereotactic body radiotherapy (SBRT) plan quality assurance. MATERIALS AND METHODS: The detector was integrated into its accompanying phantom or in Water Equivalent Plastic (WEP). The measurement reproducibility, stability, dose linearity and dependence on angularity, dose rate and field size were investigated. Clinical plan measurements were compared to our radiotherapy treatment planning system and radiochromic film. Sensitivity to introduced Multi Leaf Collimator (MLC) offsets was evaluated by simulating single MLC offsets in SBRT plans and comparing measurements to expected doses. RESULTS: Signal reproducibility was within ± 0.1 % and output calibration was stable over a 6 month period. Detector showed good linearity with dose (r(2) = 1). Signal decreased by 5 % when dose rate was decreased from 1300 MU/min to 300 MU/min. Output factors agreed within 0.5 % of chamber measurements for 1x1 cm field sizes or greater. Angularity measurements showed good agreement with reference. For measurement of planned clinical doses, gamma pass-rates were 98.5 % ± 2.3 % (treatment planning system reference, 2 %/2mm) and 99.2 % ± 1.0 % (film reference, 2 %,2mm). The detector also showed sensitivity to errors of 1 mm offsets in MLC positioning. CONCLUSION: The detector performed well when used for pre-treatment SBRT plan quality assurance, offering a good alternative to radiochromic film.
format Online
Article
Text
id pubmed-9900433
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99004332023-02-07 Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance Stepanek, Chris J. Haynes, Jackie A. Fletcher, Sally Phys Imaging Radiat Oncol Original Research Article BACKGROUND AND PURPOSE: A sub-mm resolution Complementary Metal Oxide Semiconductor sensor has been developed for stereotactic radiotherapy quality assurance. Herein we evaluate its basic dosimetric performance and its application for linac C-arm stereotactic body radiotherapy (SBRT) plan quality assurance. MATERIALS AND METHODS: The detector was integrated into its accompanying phantom or in Water Equivalent Plastic (WEP). The measurement reproducibility, stability, dose linearity and dependence on angularity, dose rate and field size were investigated. Clinical plan measurements were compared to our radiotherapy treatment planning system and radiochromic film. Sensitivity to introduced Multi Leaf Collimator (MLC) offsets was evaluated by simulating single MLC offsets in SBRT plans and comparing measurements to expected doses. RESULTS: Signal reproducibility was within ± 0.1 % and output calibration was stable over a 6 month period. Detector showed good linearity with dose (r(2) = 1). Signal decreased by 5 % when dose rate was decreased from 1300 MU/min to 300 MU/min. Output factors agreed within 0.5 % of chamber measurements for 1x1 cm field sizes or greater. Angularity measurements showed good agreement with reference. For measurement of planned clinical doses, gamma pass-rates were 98.5 % ± 2.3 % (treatment planning system reference, 2 %/2mm) and 99.2 % ± 1.0 % (film reference, 2 %,2mm). The detector also showed sensitivity to errors of 1 mm offsets in MLC positioning. CONCLUSION: The detector performed well when used for pre-treatment SBRT plan quality assurance, offering a good alternative to radiochromic film. Elsevier 2023-01-24 /pmc/articles/PMC9900433/ /pubmed/36755894 http://dx.doi.org/10.1016/j.phro.2023.100418 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Stepanek, Chris J.
Haynes, Jackie A.
Fletcher, Sally
Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
title Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
title_full Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
title_fullStr Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
title_full_unstemmed Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
title_short Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
title_sort evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900433/
https://www.ncbi.nlm.nih.gov/pubmed/36755894
http://dx.doi.org/10.1016/j.phro.2023.100418
work_keys_str_mv AT stepanekchrisj evaluationofacomplementarymetaloxidesemiconductordetectorasatoolforstereotacticbodyradiotherapyplanqualityassurance
AT haynesjackiea evaluationofacomplementarymetaloxidesemiconductordetectorasatoolforstereotacticbodyradiotherapyplanqualityassurance
AT fletchersally evaluationofacomplementarymetaloxidesemiconductordetectorasatoolforstereotacticbodyradiotherapyplanqualityassurance